SOX6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.508840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.701600E-01
Normal-vs-Stage2
1.641250E-01
Normal-vs-Stage3
2.186400E-01
Normal-vs-Stage4
5.947800E-01
Stage1-vs-Stage2
5.959600E-02
Stage1-vs-Stage3
5.592000E-02
Stage1-vs-Stage4
4.112800E-01
Stage2-vs-Stage3
2.312800E-01
Stage2-vs-Stage4
6.201400E-01
Stage3-vs-Stage4
1.704380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.207000E-01
Normal-vs-AfricanAmerican
6.222400E-01
Normal-vs-Asian
2.047400E-01
Caucasian-vs-AfricanAmerican
3.719200E-01
Caucasian-vs-Asian
5.674000E-01
AfricanAmerican-vs-Asian
2.971000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.599580E-01
Normal-vs-Female
1.703630E-01
Male-vs-Female
9.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.418600E-01
Normal-vs-Age(41-60Yrs)
3.408400E-01
Normal-vs-Age(61-80Yrs)
4.750400E-01
Normal-vs-Age(81-100Yrs)
4.217600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.563150E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.163800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.218200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.899500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.019790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.702400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.104800E-01
Normal-vs-Daily Drinker
3.702000E-01
Normal-vs-Weekly Drinker
4.342000E-01
Normal-vs-Occasional Drinker
1.524230E-01
Normal-vs-Social Drinker
5.081400E-01
Non Drinker-vs-Daily Drinker
5.887900E-02
Non Drinker-vs-Weekly Drinker
4.769200E-01
Non Drinker-vs-Occasional Drinker
7.127600E-01
Non Drinker-vs-Social Drinker
3.713600E-01
Daily Drinker-vs-Weekly Drinker
4.688600E-01
Daily Drinker-vs-Occasional Drinker
2.467200E-01
Daily Drinker-vs-Social Drinker
6.471500E-02
Weekly Drinker-vs-Occasional Drinker
7.390000E-01
Weekly Drinker-vs-Social Drinker
2.181200E-01
Occasional Drinker-vs-Social Drinker
3.008800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.686500E-02
Normal-vs-Grade 2
8.373500E-02
Normal-vs-Grade 3
9.744400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.494200E-01
Grade 1-vs-Grade 3
6.653200E-01
Grade 1-vs-Grade 4
6.686500E-02
Grade 2-vs-Grade 3
3.528600E-01
Grade 2-vs-Grade 4
8.373500E-02
Grade 3-vs-Grade 4
9.744400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.810400E-01
Normal-vs-NonDiabetic
4.752400E-01
Diabetic-vs-NonDiabetic
9.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.330000E-01
Normal-vs-NoPancreatitis
4.851000E-01
Pancreatitis-vs-NoPancreatitis
5.892600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.762400E-01
Normal-vs-N1
1.909230E-01
N0-vs-N1
3.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.942200E-01
Normal-vs-TP53-NonMutant
7.085400E-01
TP53-Mutant-vs-TP53-NonMutant
1.315840E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
